Skip to content

Net margin at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
-48.4%+240pp
ALN
Alnylam PharmaceuticalsALNY
11.7%+8.0pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-7,965.8%-10,750pp
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
84%+43.4pp
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-676%-291pp
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
-51.1%-9.9pp

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Calculated from Assembly Biosciences’s reported figures.

Based on trailing twelve months.

The official record: Assembly Biosciences’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's net margin?
Assembly Biosciences (ASMB) reported net margin of -103.6% in Q3 2025.
How has Assembly Biosciences's net margin changed year-over-year?
Assembly Biosciences's net margin increased by 28.0% year-over-year, from -144.1% to -103.6%.
What is the long-term trend for Assembly Biosciences's net margin?
Over 2 years (2020 to 2024), Assembly Biosciences's net margin has grown at a 33.9% compound annual growth rate (CAGR), from -78.6% to -140.9%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.